Skip to Main Content

Paper Details

Frequent Loss of IRF2 in Cancers Leads to Immune Evasion through Decreased MHC Class I Antigen Presentation and Increased PD-L1 Expression.
J Immunol
52
2019
CD8+, CD8+ T cells, Cancers, ERAP1, HeLa cells, IFN, IRF1, IRF2, MHC Class I, MHC class I, MHC-I, MHC-I Ag, N, PD-L1, TAP, cancers, human, humans, lung, colon, breast, prostate, mice, nonessential gene, transcription factor IRF2, tumor, tumors
Author NameAffiliation
Abraham L BrassUniversity of Massachusetts Medical School
Abraham L BrassUniversity of Massachusetts Medical School
Abraham L Brass
Abraham L BrassUniversity of Massachusetts Medical School
Abraham L BrassUniversity of Massachusetts Medical School
Abraham L Brass
Manuel GarberUniversity of Massachusetts Medical School
  • 1 - 7

Datasets

Release 1.2